In vitro activity of telavancin in combination with colistin versus gram-negative bacterial pathogens

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 6, 2012, Pages 3080-3085

  Hornsey, Michael ^a   Longshaw, Christopher ^b   Phee, Lynette ^a,c   Wareham, David W ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Astellas Pharma Europe   (United Kingdom)

^c BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; TELAVANCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA;

ACINETOBACTER BAUMANNII; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; COLISTIN; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; POLYMYXINS; PSEUDOMONAS AERUGINOSA;

EID: 84861173941     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05870-11     Document Type: Article

References (28)

1. Beceiro A, et al. 2011. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob. Agents Chemother. 55:3370-3379.
2. Bergen PJ, et al. 2011. Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob. Agents Chemother. 55:5685-5695.
3. Doyle JS, Buising KL, Thursky KA, Worth LJ, Richards MJ. 2011. Epidemiology of infections acquired in intensive care units. Semin. Respir. Crit. Care Med. 32:115-138.
4. Gordon NC, Png K, Wareham DW. 2010. Potent synergy and sustained bactericidal activity of a vancomycin-colistin combination versus multidrug- resistant strains of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:5316-5322.
5. Gordon NC, Wareham DW. 2010. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int. J. Antimicrob. Agents 35:219-226.
6. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 53: 60-67.
7. Ho J, Tambyah PA, Paterson DL. 2010. Multiresistant Gram-negative infections: a global perspective. Curr. Opin. Infect. Dis. 23:546-553.
8. Hornsey M, Wareham DW. 2011. In vivo efficacy of glycopeptidecolistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 55:3534-3537.
9. Jiang SS, et al. 2010. Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion. Antimicrob. Agents Chemother. 54:1564-1571.
10. King A. 2001. Recommendations for susceptibility tests on fastidious organisms and those requiring special handling. J. Antimicrob. Chemother. 48(Suppl. 1):77-80.
11. Lee H, Hsu FF, Turk J, Groisman EA. 2004. The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 186:4124-4133. (Pubitemid 38802559)
12. Livermore DM. 2011. Discovery research: the scientific challenge of finding new antibiotics. J. Antimicrob. Chemother. 66:1941-1944.
13. Lunde CS, et al. 2009. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. Antimicrob. Agents Chemother. 53:3375-3383.
14. Micek ST. 2007. Alternatives to vancomycin for the treatment of methicillin- resistant Staphylococcus aureus infections. Clin. Infect. Dis. 45(Suppl. 3):S184-S190. (Pubitemid 47378905)
15. Milne KE, Gould IM. 2010. Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index. J. Antimicrob. Chemother. 65:82-90.
16. Pankuch GA, Appelbaum PC. 2009. Postantibiotic effects of telavancin against 16 gram-positive organisms. Antimicrob. Agents Chemother. 53: 1275-1277.
17. Paul M, et al. 2010. Effectiveness and safety of colistin: prospective comparative cohort study. J. Antimicrob. Chemother. 65:1019-1027.
18. Rattanaumpawan P, Lorsutthitham J, Ungprasert P, Angkasekwinai N, Thamlikitkul V. 2010. Randomized controlled trial of nebulized colisti- methate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. J. Antimicrob. Chemother. 65: 2645-2649.
19. 14C]telavancin following intravenous administration to healthy male volunteers. Antimicrob. Agents Chemother. 54:3365-3371.
20. Stryjewski ME, et al. 2008. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by grampositive organisms. Clin. Infect. Dis. 46:1683-1693. (Pubitemid 351706765)
21. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
22. Vaara M, et al. 2008. Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents. Antimicrob. Agents Chemother. 52:3229-3236.
23. Vaara M, et al. 2010. A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane. Antimicrob. Agents Chemother. 54:3341-3346.
24. Vila-Farres X, et al. 2011. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii. Clin. Microbiol. Infect. 18:383-387.
25. Wareham DW, Gordon NC, Hornsey M. 2011. In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother. 66:1047-1051.
26. Woodford N, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27: 351-353.
27. Woodford N, Turton JF, Livermore DM. 2011. Multiresistant Gramnegative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
28. Yandek LE, Pokorny A, Almeida PF. 2009. Wasp mastoparans follow the same mechanism as the cell-penetrating peptide transportan 10. Biochemistry 48:7342-7351.